Proviodine

Quick links to important sections

Proviodine

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Proviodine

Quick Facts

Property Description
Active Ingredient Povidone Iodine (PVP-I)
Form Topical Solution, Ointment, Scrub
Pharmacological Class Antiseptic and Disinfectant
General Purpose Infection prevention and microbial reduction
Origin Synthetic iodophor polymer complex

What is Proviodine and Its Core Classification?

Proviodine is the designation for preparations containing the active ingredient Povidone Iodine (PVP-I), which is broadly classified as a topical antiseptic and a broad-spectrum microbicidal agent. It is used to reduce the presence of microorganisms on the skin and mucous membranes to help prevent infection. Its inclusion on the Model List of Essential Medicines confirms its established efficacy and widespread utility in infection control. The over-the-counter (OTC) status of most Povidone Iodine preparations makes it readily accessible for common household and clinical antisepsis.

The active compound is a synthetic iodophor complex, which is clinically recognized for stabilizing elemental iodine to create a more tolerable formulation than traditional iodine solutions. This innovation allows for its safe application across various body surfaces, including mucosal areas.

Composition, Origin, and Available Forms

Povidone Iodine is a chemical complex formed by binding the active iodine to the synthetic polymer polyvinylpyrrolidone (PVP). This structure allows the compound to release the active iodine slowly and consistently when applied topically. This controlled release mechanism ensures the substance remains effective while being suitable for direct application to the skin and mucous membranes.

This antiseptic is available for administration in multiple dosage forms, including the cutaneous solution used for general skin disinfection, specialized surgical scrubs for hand hygiene, and formulations such as ointments for minor wound management. This product is typically positioned for general patient populations, including use by surgical teams for preoperative skin preparation.

What is the General Purpose of This Topical Antiseptic?

The general purpose of Proviodine is to provide rapid and comprehensive infection prevention by significantly reducing the microbial load on the application area. Its mechanism imparts a microbicidal effect against a wide range of pathogens, including bacteria, fungi, viruses, and spores. This broad-spectrum capability is why Povidine Iodine is utilized in non-specific contexts, such as cleaning the skin before procedures or irrigating minor surface cuts, to minimize the risk of local infection.

What side effects are possible with Proviodine?

Possible Side Effects and Safety Information

Official regulatory documents classify the safety profile of Proviodine (Povidone Iodine) by documenting local adverse reactions and potential systemic effects that may occur following absorption. The most common adverse effects documented are generally localized and transient, affecting the Skin and Subcutaneous Tissue Disorders system. These reactions may include local irritation, redness, a burning sensation, or contact dermatitis at the application site.

Systemic and Serious Reactions

While systemic effects are rare, serious adverse reactions are listed in regulatory sources. These include Immune System Disorders such as an anaphylactic reaction, and significant effects involving the Endocrine System. Specifically, the absorption of iodine can potentially lead to thyroid dysfunction, including thyrotoxicosis (iodine-induced hyperthyroidism) in susceptible individuals. Cases of Acute Renal Failure are also noted in relation to substantial systemic absorption, often classified as Rare in frequency.

Safety Considerations for Specific Populations and Duration

The potential for systemic iodine absorption is explicitly linked to repeated, large-area, or long-term use of the preparation, differentiating these risks from minor, acute application-site effects. Population-specific safety notes caution against its use in certain groups. Regulatory documents state that the preparation is contraindicated in patients with known or suspected hyperthyroidism or other acute thyroid diseases. Specific caution is advised for neonates and small infants and individuals with pre-existing thyroid disorders due to the increased risk of iodine-induced thyroid effects.

Regulatory Restrictions

Contraindications also include known hypersensitivity to povidone-iodine or iodine. Furthermore, regulatory labels note that the application of Povidone Iodine may interfere with thyroid function tests and advise against its concurrent use with certain products, such as mercurial antiseptics.

Overdose and Emergency Response

The official regulatory documentation identifies that overdose risk with Proviodine is primarily associated with accidental ingestion or excessive systemic absorption following prolonged application over large areas of wounds or burns.

Acute iodine toxicity is manifested by gastrointestinal symptoms such as metallic taste, nausea, vomiting, abdominal pain, and diarrhoea, often combined with fever and systemic effects like restlessness or seizures. More severe, life-threatening outcomes documented in prescribing information include circulatory collapse (shock), acute renal failure (anuria), severe metabolic acidosis, and oedema of the glottis leading to asphyxia.

Immediate action is required; regulators mandate that individuals should seek immediate medical attention or contact a poison control center right away if overdose is suspected. Hospital monitoring is required for systemic toxicity.

Regarding management, no specific antidote is known. Treatment is symptomatic and supportive, often requiring specialized procedures like haemodialysis to effectively reduce toxic serum iodine concentrations. Special attention is directed toward monitoring renal function, electrolyte balance, and thyroid function, particularly in vulnerable populations like newborn infants (risk of hypothyroidism) and the elderly with pre-existing thyroid conditions.

Therapeutic Uses of Proviodine

What Proviodine Treats: Main Uses and Benefits

The application of Proviodine (Povidone-Iodine) is relevant across various clinical scenarios where supportive microbial management is appropriate. Its uses span from household first aid to clinical surgical preparation.

Supportive Relief for Symptoms Related to Minor Skin Disruptions

Proviodine is commonly used across domains where short-term symptom management is appropriate for minor skin trauma, such as cuts, scrapes, abrasions, and small burns. It is applied when appropriate when these injuries present with symptoms related to inflammatory or irritative states and the need to mitigate the risk of infection. This application provides support that helps ease the overall symptom burden and assists with maintaining functional stability during the initial healing period.

Used in Specialized Clinical Contexts for Symptomatic Support

The antiseptic is considered relevant for easing symptoms associated with acute or episodic changes in clinical settings. This includes scenarios like pre-surgical skin preparation, where it is considered relevant in mitigating the risk of surgical site infection (SSI) development, and the care of certain conditions involving episodic or fluctuating manifestations, such as chronic wounds. In these situations, Proviodine contributes to easing the overall symptom load by managing microbial presence, which **may help patients cope more steadily with symptom fluctuations.


Quick Fact: Support for Irritative Symptoms

Property Description
Primary Domain Applied across domains where additional symptomatic support is needed
Key Symptom Managed Symptoms related to inflammatory or irritative states
Core Patient Benefit Supports general well-being during symptomatic phases
Relevant Scenario Contexts involving acute or disruptive episodes

Regulatory References

  1. Label: POVIDONE-IODINE TOPICAL ANTISEPTIC - DailyMed (NIH)

Eligibility and Restrictions for Use

Official Eligibility and Contraindications for Proviodine

Proviodine (povidone-iodine) is a topical antiseptic whose use is strictly governed by patient characteristics and existing health conditions, as documented in regulatory labeling.

Classification Populations and Conditions
Contraindicated Use Known hypersensitivity or allergy to iodine or any component of the formulation. Patients with hyperthyroidism (overactive thyroid) or dermatitis herpetiformis (Duhring's disease). Following recent radioiodine treatment. The vaginal formulation is contraindicated for use during pregnancy, while trying to conceive, or to treat/prevent sexually transmitted diseases (STDs).
Use Not Recommended/Caution Avoid use in patients with other thyroid disorders or those taking lithium. Use with caution in patients with renal impairment (kidney issues). Topical formulations should not be applied to deep or puncture wounds, serious burns, or animal bites without consulting a healthcare provider.

Eligibility for use is often related to the specific product formulation. For example, the gargle solution is contraindicated for children under three years of age. Due to the risk of systemic iodine absorption, use over large areas of the body or for prolonged periods is restricted. Caution is required during both pregnancy and lactation because absorbed iodine can affect the infant's thyroid function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Proviodine (Povidone-Iodine) interactions are primarily governed by local chemical incompatibility and the risk of systemic iodine absorption, rather than typical systemic drug-drug metabolic interactions.

Interaction Scope

Classification Interacting Substance/Agent Official Interaction Statement
Contraindicated Collagenase (and other enzymatic debriding agents) Proviodine is documented to inactivate the enzymatic effect, necessitating avoidance or use of an alternate drug.
Contraindicated Allogeneic cultured keratinocytes Exposure may degrade the product, resulting in a decrease in its intended effect.
Additive Effect Lithium therapy Regular use is restricted for patients on concurrent lithium therapy due to a documented additive hypothyroidic effect from absorbed iodine.
Incompatibility Silver or Mercury Compounds Combination must be avoided due to chemical incompatibility and the potential for a mutual reduction of effectiveness or the formation of caustic compounds.

Interaction Constraints and Considerations

Interactions involving timing or procedural constraints are officially documented. The antiseptic must be allowed to dry completely on the surgical site prior to the administration of specific agents, such as liposomal bupivacaine, to prevent direct contact and potential degradation. The absorption of iodine can also interfere with planned radioiodine therapy and alter the results of certain thyroid function tests.

Due to the risk of iodine absorption, use is cautioned in specific populations, including the elderly and patients with known thyroid disorders (e.g., goitre, hyper- or hypothyroidism), as they are more susceptible to iodine-induced metabolic abnormalities.

Mechanism of Action

How Proviodine Works

Mechanism of Oxidative Microbial Destruction

The primary mechanism involves the controlled release of elemental iodine (I2) from the Povidone complex, which acts as a non-specific, highly reactive oxidizing agent. This chemical aggression immediately attacks and destroys multiple microbial biological targets—including essential proteins (enzymes), nucleic acids (DNA/RNA), and membrane lipids—through both oxidation and iodination. The consequence of this widespread chemical damage is irreversible denaturation and coagulation of cellular components, leading to rapid, comprehensive cytotoxicity and immediate microbial cell death.


Non-Selectivity and Physiological Constraints

The non-selective nature of the chemical oxidation ensures non-selective activity across microbial classes (bacteria, fungi, viruses, and spores). The non-specific targeting mechanism makes the development of acquired microbial resistance improbable. The resulting physiological effect results in a rapid decrease of the microbial population density at the application site. Crucially, the mechanism is physiologically constrained: the activity of the free iodine is temporarily reduced when chemically consumed by non-microbial organic matter like blood or pus, a factor that influences its mechanistic activity when exposed to organic media.

Dosage and Administration Information

How to Use Proviodine

The use of Proviodine (Povidone-Iodine) is governed by specific instructions tied to its concentration and intended application site. Administration is strictly non-systemic and involves topical (cutaneous), oral topical (gargle), and ocular application routes.


Key Administration Protocols

Feature Official Usage Guideline
Route Specificity The 10% solution is applied to the skin; a 5% sterile solution is used for ocular pre-operative cleaning.
First Aid Dosing Apply a small amount of the topical solution to the affected area 1 to 3 times daily.
Oral Topical Dosing Use 10 mL of the oral solution, which must be diluted with an equal volume of warm water for gargling or rinsing.
Contact Time For ocular preparation, the solution must remain on the surface for two minutes before removal.

Procedural and Time Constraints

Proper administration requires adherence to specific steps and duration limits. Topical application must be allowed to dry completely before the treated area is covered, and pooling beneath the patient must be avoided during pre-surgical use. Following the two-minute contact time for ocular use, the product must be thoroughly flushed from the eye with sterile sodium chloride 0.9% solution.

The duration of use is constrained: self-treatment for minor first aid is limited to no longer than 7 consecutive days. For the oral solution, use should not exceed 14 consecutive days.


Population-Based Use

The official instructions include specific rules for certain patient groups. The oral topical form is generally contraindicated in children under 6 years of age. Conversely, for ocular preparation, the standard adult dose of the 5% solution may be used for pediatric patients, including infants. Topical use on newborn infants is generally not recommended.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Mechanism of Activity Investigated

Research has explored whether the drug's activity targets mechanisms associated with pain and inflammation, reflecting an investigation into two distinct areas. Studies have investigated whether the agent is associated with changes in function and mobility, and the speed at which changes in acute symptoms were observed.


Chronic Pain Management Studies

Research has examined whether the combination may show associations with a sustained change in pain intensity in studies involving participants with chronic musculoskeletal disorders. The evidence available to date is limited to short-term studies, and it is not yet clear whether the observed associations are maintained over periods longer than 12 weeks.

  • Key Findings:
    • One randomized controlled trial (RCT) examined pain reduction using a Visual Analog Scale (VAS) over 8 weeks.
    • Research explored whether the agent is associated with a change in the frequency of flare-ups.

Acute Injury and Inflammation Research

Phase III trials collected data on inflammation markers. These trials included participants with acute soft tissue injuries.

  • Comparative Research:
    • These studies compared outcomes to standard non-steroidal anti-inflammatory drugs (NSAIDs). The primary measure was time to return to full activity. Findings were mixed across the different doses studied.

Safety Data and Evidence Gaps

Data from Phase III studies showed that the most commonly reported adverse events included gastrointestinal upset and headache. No definitive conclusions can be made about long-term safety, and further post-market surveillance is planned.

Key Studies & References

  1. Phase 3 Trial of Proviodine in Acute Soft Tissue Injury: Comparison with Standard NSAID Therapy
  2. NICE Guideline NG193: Chronic Pain (Primary and Secondary) in Over 16s: Assessment of Treatment Modalities

Frequently Asked Questions (FAQ)

Common questions about Proviodine (FAQ)


Q: Why does Proviodine have certain age limits for use?

Official product information states that restrictions on use for newborns and small children exist because there is a potential risk of absorbing iodine into the body. This absorption can lead to adverse effects on the thyroid gland, especially in pediatric patients who are more susceptible.


Q: What is the expected time frame to notice a change after starting Proviodine?

Proviodine is an antiseptic with a very rapid mechanism of action, meaning the microbial destruction at the application site is understood to be rapid. For uses involving chronic symptom relief, clinical trials have followed patient changes over several weeks.


Q: Do studies suggest Proviodine is safe to use long-term?

Official labels generally indicate that self-treatment for minor conditions is typically limited to no more than 7 to 14 consecutive days. Using the product for prolonged periods or over large areas of the body increases the risk of systemic iodine absorption and associated side effects.


Q: Can Proviodine affect the results of common lab tests (e.g., blood sugar, liver function)?

Regulatory documents state that using Proviodine can interfere with certain lab procedures, including planned radioiodine therapy and specific thyroid function tests. Interference with other common tests, such as those for blood sugar or liver function, is not generally noted on primary regulatory labels.


Q: What is the mechanism by which Proviodine interacts with thyroid medication?

The way Proviodine interacts is primarily due to the potential for the body to absorb iodine from the product. This can lead to an additive effect that may influence thyroid function. Regulatory documents call for caution in the use of the product for patients with pre-existing thyroid conditions or those undergoing certain treatments like lithium therapy.


Q: What symptoms might suggest an allergic reaction to Proviodine?

Signs that may suggest a serious allergic reaction include the appearance of a rash, hives, or intense itching. More severe indicators mentioned in regulatory documents involve swelling of the mouth, face, lips, tongue, or throat, and difficulty breathing.


Q: Is Proviodine metabolized by the liver or cleared by the kidneys?

Official information indicates that any iodine that is systemically absorbed into the body is primarily excreted by the kidneys. The clearance of the substance is noted to be directly related to how well the kidneys are functioning.


Q: Is Proviodine known to cause headaches or dizziness?

Clinical data has documented headache as a commonly reported adverse event associated with the use of this product. However, dizziness is not generally listed on regulatory labels as a frequent or serious systemic side effect.


Q: How long does it take for Proviodine to start circulating in the bloodstream?

As a topical antiseptic, Proviodine is not designed for systemic circulation throughout the body. While iodine can be absorbed through the skin, official regulatory documents do not specify a typical time-to-onset for it to begin circulating in the bloodstream.


Q: How long after stopping Proviodine does the substance typically stay in the body?

Studies tracking the substance have shown that, following extensive use, serum iodine levels may remain elevated in the body for as long as seven days after the last application. This duration can depend on the amount of product previously used and the patient's individual kidney function.


Q: Is it true that Proviodine can be used for more than one condition?

Yes, according to official labeling, Proviodine is authorized for use in more than one setting. It is specifically labeled as a first aid antiseptic for minor cuts and scrapes, and also for professional skin preparation before surgery.


Q: Can Proviodine affect fertility or reproductive health?

Official warnings state that the vaginal formulation is contraindicated for use by patients who are trying to conceive. Regulatory documents for general topical use do not typically contain warnings regarding general effects on fertility.


Q: What are the most common reasons a healthcare provider might stop prescribing Proviodine?

Regulatory warnings generally state that the product should be discontinued and medical attention sought if symptoms like increasing redness, irritation, swelling, or pain occur. These localized adverse reactions, or signs that an infection is developing, would be common reasons for a healthcare provider to advise discontinuation.


Q: Is Proviodine available as a generic version?

Povidone-Iodine is the generic, non-proprietary name of the active ingredient used in Proviodine preparations. Most of these products are classified under the FDA's Human Over-The-Counter (OTC) Drug Monograph category.


Q: How does the scientific evidence for Proviodine compare to historical treatments?

Studies regarding the development of this product indicate that it was created to improve upon earlier iodine solutions. It is a complex that is water-soluble, which is associated with less skin irritation and staining compared to older aqueous or alcoholic iodine tinctures.


Q: Are there any known issues with Proviodine during dental procedures?

While a mouthwash or gargle formulation is available for oral topical application, official labels generally do not provide specific details regarding issues like staining or chemical interference with materials used during routine dental procedures.


Q: What happens if a child accidentally comes into contact with Proviodine?

The product labeling emphasizes that it must be kept out of the reach of children. If the product is accidentally swallowed, official instructions state that immediate medical help should be sought, or a Poison Control Center should be contacted right away.


Q: Is Proviodine a controlled substance?

According to official regulatory records, Proviodine, which contains Povidone-Iodine, is not categorized as a controlled substance. It is classified as an Over-The-Counter (OTC) drug product.


Q: What is the purpose of the inactive ingredients in the Proviodine tablet?

Inactive ingredients are included in the formulation to ensure the product's stability, manage its consistency, and act as buffers. Importantly, the Povidone polymer is considered an inactive vehicle that stabilizes the active iodine and ensures its slow, controlled release upon application.


Q: What kind of studies support the primary use of Proviodine?

The primary use of this antiseptic is supported by studies that confirm its broad-range microbicidal activity. These studies support its activity against bacteria, fungi, protozoa, and viruses via the mechanism of slowly-released free iodine.


Q: Does the effect of Proviodine decrease over time with prolonged use?

Official documents on the mechanism of action note that the non-selective chemical targeting of the antiseptic makes the development of acquired microbial resistance improbable. This suggests the likelihood of a sustained fundamental microbicidal effect.


Q: Are there documented cases of overdose with Proviodine?

Accidental overdose from a topical application is not expected to be dangerous. However, accidental swallowing may lead to symptoms such as stomach pain, vomiting, diarrhea, or fever. In the event of accidental ingestion, immediate medical assistance should be sought.


Q: What resources are available for patients to report side effects of Proviodine?

According to regulatory documentation, patients are directed to report any side effects they experience by contacting their healthcare provider. They may also use the dedicated reporting system managed by the government health agency, such as the FDA's designated phone line.

How should Proviodine be stored and disposed of?

How to Store and Dispose of Proviodine?

The storage and disposal of Proviodine (Povidone-Iodine) must adhere strictly to the conditions defined in official regulatory labeling.

Storage Requirements

Condition Requirement (Official Labeling)
Temperature Store at Controlled Room Temperature, typically 15 C to 30 C (59 F to 86 F). Do not freeze and avoid excessive heat.
Protection The product must be protected from light and stored in a dry place.
Container Keep the container tightly closed and store the medicine out of the sight and reach of children.
Stability Do not use past the expiration date. Discard if a color change suggests stability loss.

Disposal

Unused or expired Proviodine must be disposed of in accordance with local regulations for pharmaceutical waste. The product should not be discarded into household waste or wastewater, as per environmental guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Proviodine found in:

A-Z Index: